Biotech2 hours ago
Legend Biotech: Growth Driven by CAR-T Innovation and Carvykti Expansion
Legend Biotech's stock reflects demand for innovative CAR-T cancer therapies. The US biotech focuses on commercializing Carvykti with partner Janssen while expanding its pipeline. Approved revenue...